NOVAVAX INC
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-32.8M | $-33.6M | $745.0K | $1.5M |
| FY2010 | $-32.9M | $-34.4M | $1.6M | $1.3M |
| FY2011 | $-23.6M | $-24.2M | $610.0K | $2.0M |
| FY2012 | $-18.2M | $-22.6M | $4.3M | $2.1M |
| FY2013 | $-45.4M | $-51.1M | $5.8M | $2.5M |
| FY2014 | $-67.0M | $-74.3M | $7.3M | $6.1M |
| FY2015 | $-126.1M | $-144.4M | $18.3M | $13.4M |
| FY2016 | $-258.8M | $-277.0M | $18.2M | $19.2M |
| FY2017 | $-144.5M | $-148.7M | $4.2M | $19.8M |
| FY2018 | $-184.8M | $-186.2M | $1.4M | $18.3M |
| FY2019 | $-136.6M | $-138.5M | $1.9M | $17.0M |
| FY2020 | $-42.5M | $-97.2M | $54.6M | $128.0M |
| FY2021 | $322.9M | $265.5M | $57.5M | $183.6M |
| FY2022 | $-415.9M | $-415.9M | — | $130.3M |
| FY2023 | $-714.0M | $-714.0M | — | $85.4M |
| FY2024 | $-87.3M | $-87.3M | — | $48.2M |
| FY2025 | $-244.6M | $-244.6M | — | $36.0M |